206 results on '"Verstraete, Alain G."'
Search Results
2. Development and evaluation of uncertainty quantifying machine learning models to predict piperacillin plasma concentrations in critically ill patients
3. Pilot study of oral fluid and plasma meropenem and piperacillin concentrations in the intensive care unit
4. Quantification of eight hematological tyrosine kinase inhibitors in both plasma and whole blood by a validated LC-MS/MS method
5. Development, validation and application of an inductively coupled plasma – mass spectrometry method to determine cobalt in metal-on-metal prosthesis patients using volumetric absorptive microsampling
6. Subtherapeutic piperacillin concentrations in neurocritical patients
7. Automation in Busulfan Therapeutic Drug Monitoring: Evaluation of an Immunoassay on Two Routine Chemistry Analyzers
8. Prevalence of therapeutic drugs in blood of drivers involved in traffic crashes in the area of Bologna, Italy
9. Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational study
10. Development and validation of an ultra-high performance liquid chromatography – high resolution mass spectrometry method for the quantification of total and free teicoplanin in human plasma
11. Automation in Microsampling
12. Pretomanid-resistant tuberculosis
13. Δ9-Tetrahydrocannabinol concentrations in exhaled breath and physiological effects following cannabis intake – A pilot study using illicit cannabis
14. Measuring Unbound Versus Total Piperacillin Concentrations in Plasma of Critically Ill Patients: Methodological Issues and Relevance
15. Pretomanid-resistant tuberculosis
16. Detection of illicit drugs in oral fluid from drivers as biomarker for drugs in blood
17. Assays for therapeutic drug monitoring of β-lactam antibiotics: A structured review
18. Identification of etazene (etodesnitazene) metabolites in human urine by LC‐HRMS
19. Proficiency Testing for Meropenem and Piperacillin Therapeutic Drug Monitoring: Preliminary Results From the Belgian Society on Infectiology and Clinical Microbiology Pharmacokinetic–Pharmacodynamic Working Group
20. Multicenter Evaluation of a New Electrochemiluminescence Immunoassay for Everolimus Concentrations in Whole Blood
21. Analytical performance of eight enzymatic assays for ethanol in serum evaluated by data from the Belgian external quality assessment scheme
22. Joint Belgian recommendation on screening for DPD-deficiency in patients treated with 5-FU, capecitabine (and tegafur).
23. Suboptimal Beta-Lactam Therapy in Critically Ill Children: Risk Factors and Outcome
24. Automation in Busulfan Therapeutic Drug Monitoring: Evaluation of an Immunoassay on two Routine Chemistry Analyzers
25. Therapeutic Drug Monitoring of Tyrosine Kinase Inhibitors Using Dried Blood Microsamples
26. Identification of etazene (etodesnitazene) metabolites in human urine by LC‐HRMS.
27. Development and validation of a liquid chromatography high-resolution mass spectrometry orbitrap method for the sensitive quantification of amoxicillin, piperacillin, tazobactam and meropenem in human faeces
28. Exploration of the pre-analytical stability of β-lactam antibiotics in plasma and blood - implications for therapeutic drug monitoring and pharmacokinetic studies
29. Therapeutic drug monitoring of voriconazole: validation of a novel ARK™ immunoassay and comparison with ultra-high performance liquid chromatography
30. Organisation and quality monitoring for point-of-care testing (POCT) in Belgium: proposal for an expansion of the legal framework for POCT into primary health care.
31. A sensitive and high‐throughput quantitative liquid chromatography high‐resolution mass spectrometry method for therapeutic drug monitoring of 10 β ‐lactam antibiotics, linezolid and two β ‐lactamase inhibitors in human plasma
32. Long‐term chemogenetic suppression of seizures in a multifocal rat model of temporal lobe epilepsy
33. Joint Belgian recommendation on screening for DPD-deficiency in patients treated with 5-FU, capecitabine (and tegafur)
34. Organisation and quality monitoring for point-of-care testing (POCT) in Belgium: proposal for an expansion of the legal framework for POCT into primary health care
35. Joint Belgian recommendation on screening for DPD-deficiency in patients treated with 5-FU, capecitabine (and tegafur).
36. Organisation and quality monitoring for point-of-care testing (POCT) in Belgium: proposal for an expansion of the legal framework for POCT into primary health care.
37. Reformulated Architect® cyclosporine CMIA assay: improved imprecision, worse comparability between methods
38. First Report on Brorphine: The Next Opioid on the Deadly New Psychoactive Substance Horizon?
39. Corrigendum to “Early target attainment of continuous infusion piperacillin/tazobactam and meropenem in critically ill patients: A prospective observational study” [Journal of Critical Care 52 (2019) 75–79]
40. Corrigendum to “Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients”. [Int J Antimicrob Agents 51 (2018) 594–600]
41. Corrigendum to ‘Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients’ [International Journal of Antimicrobial Agents 51 (2018) 594–600]
42. Driving under the influence of drugs
43. Reformulated Architect® cyclosporine CMIA assay: improved imprecision, worse comparability between methods.
44. Multicenter Evaluation of a New Electrochemiluminescence Immunoassay for Everolimus Concentrations in Whole Blood.
45. Population pharmacokinetics and evaluation of the predictive performance of pharmacokinetic models in critically ill patients receiving continuous infusion meropenem: a comparison of eight pharmacokinetic models
46. Assessment of the results of a three-year program for National Standardization and Quality Improvement of Medical Laboratories on Drug of Abuse Testing by the Ministry of Health in Turkey
47. Population pharmacokinetics of continuous infusion of piperacillin in critically ill patients
48. A pragmatic bottom-up approach to harmonize the units of clinical chemistry tests among Belgian clinical laboratories, focusing on immunoassays
49. Ultrafast quantification of β-lactam antibiotics in human plasma using UPLC–MS/MS
50. Development and validation of an LC tandem MS assay for the quantification of β-lactam antibiotics in the sputum of cystic fibrosis patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.